Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Stefan Galluppi Insider Profile
11 Followers
Stefan Galluppi, Chief Innovation Officer at LifeMD, holds 45.45K shares in LifeMD (Ticker: LFMD). Most recently, Stefan Galluppi Bought $3,000 shares of LifeMD on Sep 12, 2024 for an estimated value of 14.79K.
Profitable Transactions
3 out of 7 Profitable Transactions
Average Return
+91.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Stefan Galluppi's holdings
Insider Roles
Chief Innovation Officer
Roles that Stefan Galluppi holds in companies
Most Profitable Insider Trade
The most profitable trade made by Stefan Galluppi
Stefan Galluppi's Trading History
List of latest transactions for each holding click on a transaction to see Stefan Galluppi's performance on stock
You May Also Like
Stefan Galluppi insider profile FAQ
What is the percentage of profitable transactions made by Stefan Galluppi?
The percentage of profitable transactions made by Stefan Galluppi is 43%.
What is the average return per transaction made by Stefan Galluppi?
The average return per transaction made by Stefan Galluppi is 91.10%.
What stocks does Stefan Galluppi hold?
Stefan Galluppi holds: LFMD stocks.
What was Stefan Galluppi’s latest transaction?
Stefan Galluppi latest transaction was an Informative Buy of $14.79K.
What was Stefan Galluppi's most profitable transaction?
Stefan Galluppi’s most profitable transaction was an Informative Buy of LFMD stock on July 22, 2019. The return on the trade was 651.50%.
What is Stefan Galluppi's role in LifeMD?
Stefan Galluppi's role in LifeMD is Chief Innovation Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.